Crystal structure and Hirshfeld surface analysis of 1-(2,4-di­chloro­benz­yl)-5-methyl-N-(thio­phene-2-sulfon­yl)-1H-pyrazole-3-carboxamide

por Aydin, Abdullah, Akkurt, Mehmet, Gur, Zehra Tugce, Banoğlu, Erden
Publicado 2018

Optimisation by Design of Experiment of Benzimidazol-2-One Synthesis under Flow Conditions

por Mostarda, Serena, Gür Maz, Tugçe, Piccinno, Alessandro, Cerra, Bruno, Banoglu, Erden
Publicado 2019

Substituted 1,2,4-Triazoles as Novel and Selective Inhibitors of Leukotriene Biosynthesis Targeting 5-Lipoxygenase-Activating Protein

por Olğaç, Abdurrahman, Çapan, İrfan, Dahlke, Philipp, Jordan, Paul M., Werz, Oliver, Banoglu, Erden
Publicado 2023

Crystal structure and Hirshfeld surface analysis of 4-(4-chloro­phen­yl)-5-methyl-3-{4-[(2-methyl­phen­yl)meth­oxy]phen­yl}-1,2-oxazole

por Aydin, Abdullah, Akkurt, Mehmet, Turanli, Sumeyye, Lengerli, Deniz, Banoglu, Erden, Ozcelik, Nefise Dilek
Publicado 2021

Synthesis and cellular bioactivities of novel isoxazole derivatives incorporating an arylpiperazine moiety as anticancer agents

por Çalışkan, Burcu, Sinoplu, Esra, İbiş, Kübra, Akhan Güzelcan, Ece, Çetin Atalay, Rengül, Banoglu, Erden
Publicado 2018

Quinazoline-4(3H)-one-7-carboxamide Derivatives as Human Soluble Epoxide Hydrolase Inhibitors with Developable 5-Lipoxygenase Activating Protein Inhibition

por Turanlı, Sümeyye, Ergül, Azize Gizem, Jordan, Paul M., Olğaç, Abdurrahman, Çalışkan, Burcu, Werz, Oliver, Banoglu, Erden
Publicado 2022

Benzoxazolone-5-Urea Derivatives as Human Soluble Epoxide Hydrolase (sEH) Inhibitors

por Gur Maz, Tugce, Koc, Beyzanur, Jordan, Paul M., İbiş, Kübra, Çalışkan, Burcu, Werz, Oliver, Banoglu, Erden
Publicado 2023

Shifting the Biosynthesis of Leukotrienes Toward Specialized Pro-Resolving Mediators by the 5-Lipoxygenase-Activating Protein (FLAP) Antagonist BRP-201

por Kretzer, Christian, Jordan, Paul M, Bilancia, Rossella, Rossi, Antonietta, Gür Maz, Tuğçe, Banoglu, Erden, Schubert, Ulrich S, Werz, Oliver
Publicado 2022

Vicinal Diaryl-Substituted Isoxazole and Pyrazole Derivatives with In Vitro Growth Inhibitory and In Vivo Antitumor Activity

por Turanlı, Sümeyye, Nalbat, Esra, Lengerli, Deniz, İbiş, Kübra, Güntekin Ergün, Sezen, Akhan Güzelcan, Ece, Muyan, Mesut, Cetin-Atalay, Rengul, Çalışkan, Burcu, Banoglu, Erden
Publicado 2022

Targeting TACC3 represents a novel vulnerability in highly aggressive breast cancers with centrosome amplification

por Saatci, Ozge, Akbulut, Ozge, Cetin, Metin, Sikirzhytski, Vitali, Uner, Meral, Lengerli, Deniz, O’Quinn, Elizabeth C., Romeo, Martin J., Caliskan, Burcu, Banoglu, Erden, Aksoy, Sercan, Uner, Aysegul, Sahin, Ozgur
Publicado 2023

Reviving immunogenic cell death upon targeting TACC3 enhances T-DM1 response in HER2-positive breast cancer

por Gedik, Mustafa Emre, Saatci, Ozge, Oberholtzer, Nathaniel, Uner, Meral, Akbulut, Ozge, Cetin, Metin, Aras, Mertkaya, Ibis, Kubra, Caliskan, Burcu, Banoglu, Erden, Wiemann, Stefan, Uner, Aysegul, Aksoy, Sercan, Mehrotra, Shikhar, Sahin, Ozgur
Publicado 2023

Encapsulation of the dual FLAP/mPEGS-1 inhibitor BRP-187 into acetalated dextran and PLGA nanoparticles improves its cellular bioactivity

por Shkodra-Pula, Blerina, Kretzer, Christian, Jordan, Paul M., Klemm, Paul, Koeberle, Andreas, Pretzel, David, Banoglu, Erden, Lorkowski, Stefan, Wallert, Maria, Höppener, Stephanie, Stumpf, Steffi, Vollrath, Antje, Schubert, Stephanie, Werz, Oliver, Schubert, Ulrich S.
Publicado 2020

Ethoxy acetalated dextran-based nanocarriers accomplish efficient inhibition of leukotriene formation by a novel FLAP antagonist in human leukocytes and blood

por Kretzer, Christian, Shkodra, Blerina, Klemm, Paul, Jordan, Paul M., Schröder, Daniel, Cinar, Gizem, Vollrath, Antje, Schubert, Stephanie, Nischang, Ivo, Hoeppener, Stephanie, Stumpf, Steffi, Banoglu, Erden, Gladigau, Frederike, Bilancia, Rossella, Rossi, Antonietta, Eggeling, Christian, Neugebauer, Ute, Schubert, Ulrich S., Werz, Oliver
Publicado 2021